Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Aug 15, 2020; 12(8): 918-930
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.918
Published online Aug 15, 2020. doi: 10.4251/wjgo.v12.i8.918
Table 3 Comparison of treatment outcomes between the endoscopic mucosal resection and endoscopic submucosal dissection groups after propensity score matching
EMR group, n = 28 | ESD group, n = 28 | P value | |
Procedure time, min | |||
Median (IQR) | 6 (3-10.75) | 87.5 (68.5-136.5) | < 0.001 |
En bloc resection, n (%) | 23 (82.1) | 26 (92.9) | 0.42 |
Complete resection, n (%) | 20 (71.4) | 25 (89.3) | 0.18 |
Closure of mucosal defects, n (%) | 24 (85.7) | 27 (96.4) | 0.35 |
Adverse events, n (%) | 1 (3.6) | 5 (17.9) | 0.19 |
Intraoperative perforation, n (%) | 0 (0) | 3 (10.7) | 0.24 |
Delayed perforation, n (%) | 0 (0) | 1 (3.6) | 1 |
Delayed bleeding, n (%) | 1 (3.6) | 0 (0) | 1 |
Emergency surgery, n (%) | 0 (0) | 1 (3.6) | 1 |
Hospital stay, d | |||
Median (IQR) | 8 (6-10.75) | 11 (8.25-14.75) | 0.006 |
Follow-up duration, mo | 23 (11-35.5) | 24 (9.75-57.5) | 0.831 |
Median (IQR) | |||
One-year follow-up, n (%) | 21 (75) | 20 (71.4) | 1 |
Local recurrence, n (%) | 1 (3.6) | 0 (0) | 1 |
Metastatic recurrence, n (%) | 0 (0) | 0 (0) | - |
- Citation: Esaki M, Haraguchi K, Akahoshi K, Tomoeda N, Aso A, Itaba S, Ogino H, Kitagawa Y, Fujii H, Nakamura K, Kubokawa M, Harada N, Minoda Y, Suzuki S, Ihara E, Ogawa Y. Endoscopic mucosal resection vs endoscopic submucosal dissection for superficial non-ampullary duodenal tumors. World J Gastrointest Oncol 2020; 12(8): 918-930
- URL: https://www.wjgnet.com/1948-5204/full/v12/i8/918.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i8.918